RxDoctor Payments Data

Irshad Hasan, MD

Family Medicine · Rossford, OHNPI 1891771184

Payments from drug & device makers

$7,684in general payments, 2019–2025

Across 533 payments — averaging $14.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$968
  • Novo Nordisk$829
  • Pfizer$649
  • Johnson & Johnson$569
  • AstraZeneca$489
  • Sanofi-aventis U.S. LLC$402
  • plus $4K from 33 others

What the payments were for

  • Food & beverage$7,678100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,684 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$152,435
Medicare patients
554
Services billed
1,475

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban521$184,306
OzempicSemaglutide72$70,049
JardianceEmpagliflozin112$50,843
FarxigaDapagliflozin Propanediol84$48,428
XareltoRivaroxaban124$44,925
XifaxanRifaximin33$43,586
Trelegy ElliptaFluticasone/Umeclidin/Vilanter67$42,355
TrulicityDulaglutide40$39,320
JanuviaSitagliptin Phosphate74$38,784
MyrbetriqMirabegron64$31,563
EntrestoSacubitril/Valsartan32$18,212
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog52$15,289
GemtesaVibegron33$13,096
Atorvastatin Calcium1,120$12,632
Lantus SolostarInsulin Glargine,hum.Rec.Anlog133$12,039

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$649$192,332548 claims
Novo NordiskOzempic$829$70,04972 claims
GSKTrelegy Ellipta, Incruse Ellipta, Breo Ellipta$180$59,858118 claims
AstraZenecaFarxiga, Breztri Aerosphere$489$59,45998 claims
Boehringer IngelheimJardiance$323$50,843112 claims
Johnson & JohnsonXarelto$569$44,925124 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$137$43,58633 claims
Lilly USA, LLCTrulicity$202$39,32040 claims
MerckJanuvia$247$38,78474 claims
Astellas Pharma US IncMyrbetriq$149$31,56364 claims
NovartisEntresto$268$18,21232 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Rossford

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →